Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Endocrinology
•
General Endocrinology
Should men with familial PCOS be screened earlier for cardiometabolic disease?
https://academic.oup.com/jcem/advance-article/doi/10.1210/clinem/dgaf121/8045448
Related Questions
How do 24-hour urine creatinine levels affect your interpretation of 24-hour urinary calcium or cortisol studies?
Is there a role for the use of SGLT2 inhibitors for the treatment of reactive hypoglycemia not responsive to dietary modifications or acarbose?
How do you approach a patient with Paget’s disease of bone with elevated alkaline phosphatase and history of chronic kidney disease?
Is inositol just as effective as metformin in treating insulin resistance associated with PCOS?
Would you prescribe testosterone to a post-menopausal woman for low libido and/or fatigue symptoms assuming all other work up is unremarkable?
What is the optimal vitamin D level for pregnant women for maternal and fetal health and how should this be supplemented in pregnancy?
What are your thoughts on trending beta-hydroxybutyrate once a diagnosis of DKA is already established?
Are thyroid molecular tests (such as Afirma, ThyroSeq) validated for use on FNA thyroid nodule samples that are not Bethesda class 3-4?
For patients on T4/T3 combination therapy for management of hypothyroidism is there an indication for monitoring T3 levels and if so, what is the appropriate timing (trough versus peak) given the pharmacokinetics of liothyronine?
In middle-aged adults with TSH 5–10 mIU/L and no symptoms, would you start levothyroxine or monitor, and does your threshold change with cardiovascular risk factors?
